The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Scopolamine Market Research Report 2024
Synopsis
Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
The global Scopolamine market was valued at US$ 11 million in 2023 and is anticipated to reach US$ 15 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
The major players in global Scopolamine market include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, etc. The top 3 players occupy about 55% shares of the global market. Australia and Europe are main markets, they occupy about 60% of the global market. Scopolamine Hydrobromide is the main type, with a share about 45%. Patches is the main application, which holds a share about 60%.
This report aims to provide a comprehensive presentation of the global market for Scopolamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Scopolamine.
Report Scope
The Scopolamine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Scopolamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Scopolamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
Segment by Type
Scopolamine Butylbromide
Scopolamine Hydrobromide
Others
Segment by Application
Tablets
Injection
Patches
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Scopolamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Scopolamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
The global Scopolamine market was valued at US$ 11 million in 2023 and is anticipated to reach US$ 15 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
The major players in global Scopolamine market include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, etc. The top 3 players occupy about 55% shares of the global market. Australia and Europe are main markets, they occupy about 60% of the global market. Scopolamine Hydrobromide is the main type, with a share about 45%. Patches is the main application, which holds a share about 60%.
This report aims to provide a comprehensive presentation of the global market for Scopolamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Scopolamine.
Report Scope
The Scopolamine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Scopolamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Scopolamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
Segment by Type
Scopolamine Butylbromide
Scopolamine Hydrobromide
Others
Segment by Application
Tablets
Injection
Patches
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Scopolamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Scopolamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Scopolamine Market Overview
1.1 Product Overview and Scope of Scopolamine
1.2 Scopolamine Segment by Type
1.2.1 Global Scopolamine Market Value Comparison by Type (2024-2030)
1.2.2 Scopolamine Butylbromide
1.2.3 Scopolamine Hydrobromide
1.2.4 Others
1.3 Scopolamine Segment by Application
1.3.1 Global Scopolamine Market Value by Application: (2024-2030)
1.3.2 Tablets
1.3.3 Injection
1.3.4 Patches
1.4 Global Scopolamine Market Size Estimates and Forecasts
1.4.1 Global Scopolamine Revenue 2019-2030
1.4.2 Global Scopolamine Sales 2019-2030
1.4.3 Global Scopolamine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Scopolamine Market Competition by Manufacturers
2.1 Global Scopolamine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Scopolamine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Scopolamine Average Price by Manufacturers (2019-2024)
2.4 Global Scopolamine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Scopolamine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Scopolamine, Product Type & Application
2.7 Scopolamine Market Competitive Situation and Trends
2.7.1 Scopolamine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Scopolamine Players Market Share by Revenue
2.7.3 Global Scopolamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Scopolamine Retrospective Market Scenario by Region
3.1 Global Scopolamine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Scopolamine Global Scopolamine Sales by Region: 2019-2030
3.2.1 Global Scopolamine Sales by Region: 2019-2024
3.2.2 Global Scopolamine Sales by Region: 2025-2030
3.3 Global Scopolamine Global Scopolamine Revenue by Region: 2019-2030
3.3.1 Global Scopolamine Revenue by Region: 2019-2024
3.3.2 Global Scopolamine Revenue by Region: 2025-2030
3.4 North America Scopolamine Market Facts & Figures by Country
3.4.1 North America Scopolamine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Scopolamine Sales by Country (2019-2030)
3.4.3 North America Scopolamine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Scopolamine Market Facts & Figures by Country
3.5.1 Europe Scopolamine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Scopolamine Sales by Country (2019-2030)
3.5.3 Europe Scopolamine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Scopolamine Market Facts & Figures by Country
3.6.1 Asia Pacific Scopolamine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Scopolamine Sales by Country (2019-2030)
3.6.3 Asia Pacific Scopolamine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Scopolamine Market Facts & Figures by Country
3.7.1 Latin America Scopolamine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Scopolamine Sales by Country (2019-2030)
3.7.3 Latin America Scopolamine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Scopolamine Market Facts & Figures by Country
3.8.1 Middle East and Africa Scopolamine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Scopolamine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Scopolamine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Scopolamine Sales by Type (2019-2030)
4.1.1 Global Scopolamine Sales by Type (2019-2024)
4.1.2 Global Scopolamine Sales by Type (2025-2030)
4.1.3 Global Scopolamine Sales Market Share by Type (2019-2030)
4.2 Global Scopolamine Revenue by Type (2019-2030)
4.2.1 Global Scopolamine Revenue by Type (2019-2024)
4.2.2 Global Scopolamine Revenue by Type (2025-2030)
4.2.3 Global Scopolamine Revenue Market Share by Type (2019-2030)
4.3 Global Scopolamine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Scopolamine Sales by Application (2019-2030)
5.1.1 Global Scopolamine Sales by Application (2019-2024)
5.1.2 Global Scopolamine Sales by Application (2025-2030)
5.1.3 Global Scopolamine Sales Market Share by Application (2019-2030)
5.2 Global Scopolamine Revenue by Application (2019-2030)
5.2.1 Global Scopolamine Revenue by Application (2019-2024)
5.2.2 Global Scopolamine Revenue by Application (2025-2030)
5.2.3 Global Scopolamine Revenue Market Share by Application (2019-2030)
5.3 Global Scopolamine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Alkaloids of Australia
6.1.1 Alkaloids of Australia Corporation Information
6.1.2 Alkaloids of Australia Description and Business Overview
6.1.3 Alkaloids of Australia Scopolamine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Alkaloids of Australia Scopolamine Product Portfolio
6.1.5 Alkaloids of Australia Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Scopolamine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Scopolamine Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Fine Chemicals Corporation
6.3.1 Fine Chemicals Corporation Corporation Information
6.3.2 Fine Chemicals Corporation Description and Business Overview
6.3.3 Fine Chemicals Corporation Scopolamine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fine Chemicals Corporation Scopolamine Product Portfolio
6.3.5 Fine Chemicals Corporation Recent Developments/Updates
6.4 Phytex Australia
6.4.1 Phytex Australia Corporation Information
6.4.2 Phytex Australia Description and Business Overview
6.4.3 Phytex Australia Scopolamine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Phytex Australia Scopolamine Product Portfolio
6.4.5 Phytex Australia Recent Developments/Updates
6.5 Alchem International
6.5.1 Alchem International Corporation Information
6.5.2 Alchem International Description and Business Overview
6.5.3 Alchem International Scopolamine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Alchem International Scopolamine Product Portfolio
6.5.5 Alchem International Recent Developments/Updates
6.6 Guangzhou Hanfang
6.6.1 Guangzhou Hanfang Corporation Information
6.6.2 Guangzhou Hanfang Description and Business Overview
6.6.3 Guangzhou Hanfang Scopolamine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Guangzhou Hanfang Scopolamine Product Portfolio
6.6.5 Guangzhou Hanfang Recent Developments/Updates
6.7 Alkaloids Corporation
6.6.1 Alkaloids Corporation Corporation Information
6.6.2 Alkaloids Corporation Description and Business Overview
6.6.3 Alkaloids Corporation Scopolamine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Alkaloids Corporation Scopolamine Product Portfolio
6.7.5 Alkaloids Corporation Recent Developments/Updates
6.8 Luyin
6.8.1 Luyin Corporation Information
6.8.2 Luyin Description and Business Overview
6.8.3 Luyin Scopolamine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Luyin Scopolamine Product Portfolio
6.8.5 Luyin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Scopolamine Industry Chain Analysis
7.2 Scopolamine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Scopolamine Production Mode & Process
7.4 Scopolamine Sales and Marketing
7.4.1 Scopolamine Sales Channels
7.4.2 Scopolamine Distributors
7.5 Scopolamine Customers
8 Scopolamine Market Dynamics
8.1 Scopolamine Industry Trends
8.2 Scopolamine Market Drivers
8.3 Scopolamine Market Challenges
8.4 Scopolamine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
